Aemetis (NASDAQ:AMTX) Releases Quarterly Earnings Results, Beats Expectations By $0.41 EPS

Aemetis (NASDAQ:AMTXGet Rating) posted its quarterly earnings data on Thursday. The specialty chemicals company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.41, Fidelity Earnings reports. During the same quarter last year, the firm earned ($0.38) EPS.

Aemetis Trading Up 24.8 %

Shares of AMTX traded up $2.02 during trading hours on Friday, reaching $10.18. 2,464,266 shares of the stock traded hands, compared to its average volume of 658,733. The stock has a fifty day simple moving average of $6.33 and a 200 day simple moving average of $9.05. Aemetis has a 52 week low of $4.45 and a 52 week high of $23.33. The company has a market cap of $352.02 million, a price-to-earnings ratio of -9.01 and a beta of 0.62.

Analyst Ratings Changes

AMTX has been the subject of several recent analyst reports. Credit Suisse Group decreased their price objective on shares of Aemetis from $35.00 to $27.00 and set an “outperform” rating for the company in a research report on Monday, June 13th. Ascendiant Capital Markets cut shares of Aemetis to an “outperform” rating and set a $33.00 price objective for the company. in a research report on Monday, June 6th. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Aemetis has an average rating of “Moderate Buy” and an average target price of $31.00.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. MetLife Investment Management LLC lifted its position in shares of Aemetis by 57.0% during the first quarter. MetLife Investment Management LLC now owns 15,153 shares of the specialty chemicals company’s stock valued at $192,000 after purchasing an additional 5,501 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Aemetis by 16.0% during the first quarter. JPMorgan Chase & Co. now owns 16,362 shares of the specialty chemicals company’s stock worth $208,000 after buying an additional 2,256 shares during the last quarter. Raymond James & Associates increased its holdings in Aemetis by 64.4% during the first quarter. Raymond James & Associates now owns 18,120 shares of the specialty chemicals company’s stock worth $230,000 after buying an additional 7,097 shares during the last quarter. Walleye Trading LLC purchased a new stake in Aemetis during the first quarter worth about $251,000. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in Aemetis during the first quarter worth about $255,000. 52.75% of the stock is owned by institutional investors.

About Aemetis

(Get Rating)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.

See Also

Earnings History for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.